Noveris Health Sciences (STU:0NF1) E10: €-242.94 (As of Mar. 2026)


STU:0NF1 Noveris Health Sciences Inc STU:0NF1
22 GF Score
Price €0.79
View Full Analysis

What is Noveris Health Sciences E10?

Noveris Health Sciences STU:0NF1 +6.04% 22 E10 is €-242.94 as of Mar. 2026. GuruFocus rates STU:0NF1 with a GF Score™ of 22/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Noveris Health Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.063. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-242.94 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-03), Noveris Health Sciences's current stock price is €0.79. Noveris Health Sciences's E10 for the quarter that ended in Mar. 2026 was €-242.94. Noveris Health Sciences's Shiller PE Ratio of today is .


Noveris Health Sciences  (STU:0NF1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Noveris Health Sciences E10 Related Terms


Noveris Health Sciences E10 Historical Data

* Premium members only.

The historical data trend for Noveris Health Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noveris Health Sciences E10 Chart

Noveris Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -20,491,563.00 -1,269.92 -1,713.15

Noveris Health Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,468.55 -2,250.42 -2,230.81 -1,713.15 -242.94

STU:0NF1 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Noveris Health Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noveris Health Sciences Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Noveris Health Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Noveris Health Sciences's Shiller PE Ratio falls into.


STU:0NF1
22GF Score
Noveris Health Sciences Inc STU:0NF1
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Noveris Health Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Noveris Health Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.063/132.2600*132.2600
=-0.063

Current CPI (Mar. 2026) = 132.2600.

Noveris Health Sciences Quarterly Data

per share eps CPI Adj_EPS
201606 -592.425 102.002 -768.166
201609 -437.977 101.765 -569.224
201612 -4,935.001 101.449 -6,433.838
201703 -2,295.606 102.634 -2,958.257
201706 -2,259.331 103.029 -2,900.348
201709 -209.961 103.345 -268.707
201712 -5,945.467 103.345 -7,608.977
201803 -1,425.190 105.004 -1,795.128
201806 -3,672.243 105.557 -4,601.219
201809 -401.411 105.636 -502.581
201812 -3,908.920 105.399 -4,905.111
201903 -347.487 106.979 -429.603
201906 -83.246 107.690 -102.239
201909 -68.575 107.611 -84.282
201912 -954.270 107.769 -1,171.129
202003 -16.207 107.927 -19.861
202006 -81.907 108.401 -99.934
202009 -128.345 108.164 -156.936
202012 -129.952 108.559 -158.323
202103 -43.106 110.298 -51.689
202106 -59.431 111.720 -70.358
202109 -31.529 112.905 -36.934
202112 -77.092 113.774 -89.618
202203 -43.033 117.646 -48.379
202206 -12.930 120.806 -14.156
202209 -13.251 120.648 -14.526
202212 17.372 120.964 18.994
202303 -19.113 122.702 -20.602
202306 -3.474 124.203 -3.699
202309 -1.385 125.230 -1.463
202312 -4.409 125.072 -4.662
202403 -0.680 126.258 -0.712
202406 -1.356 127.522 -1.406
202409 -1.071 127.285 -1.113
202412 1.441 127.364 1.496
202503 -0.155 129.181 -0.159
202506 -0.317 129.892 -0.323
202509 0.055 130.290 0.056
202512 1.585 130.370 1.608
202603 -0.063 132.260 -0.063

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-242.94 mean?
Noveris Health Sciences (STU:0NF1) has a E10 of €-242.94 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Noveris Health Sciences and its competitors.
Is Noveris Health Sciences' E10 too high?
Noveris Health Sciences' current E10 is €-242.94. Overall, Noveris Health Sciences has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Noveris Health Sciences' E10 compare to ZTS and UTHR?
Noveris Health Sciences' E10 of €-242.94 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Noveris Health Sciences and its competitors. Noveris Health Sciences's current E10 is €-242.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noveris Health Sciences stock overvalued right now?
Noveris Health Sciences (STU:0NF1) has a current E10 of €-242.94. The current E10 is €-242.94. Noveris Health Sciences' overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Noveris Health Sciences (STU:0NF1), the current E10 is €-242.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Noveris Health Sciences Business Description

Address 1890 - 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9
Noveris Health Sciences Inc is a biotech and life sciences company dedicated to developing and commercializing solutions for treating mental health problems and enhancing vitality. The company has a portfolio of patents it is seeking to commercialize, and is exploring opportunities in the stem cell industry. It is developing the next generation of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD).
22GF Score

Get the complete analysis for STU:0NF1

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.79
Price